Pirh2 Monoclonal Antibody

The protein encoded by this gene has ubiquitin ligase activity. It mediates E3-dependent ubiquitination and proteasomal degradation of target proteins, including tumor protein 53, histone deacetylase 1, and cyclin-dependent kinase inhibitor 1B, thus regulating their levels and cell cycle progression. Alternatively spliced transcript variants encoding different isoforms have been described for this gene.

The PIRH2 Monoclonal Antibody is a cutting-edge scientific tool designed to facilitate advanced research in the field of molecular biology. This high-quality antibody is specifically engineered to target and bind to the PIRH2 protein, enabling precise detection and analysis of this crucial biomarker.

With its exceptional specificity and sensitivity, the PIRH2 Monoclonal Antibody offers researchers unparalleled accuracy in their investigations. Its robust performance ensures reliable and reproducible results, making it an indispensable asset for various applications, including Western blotting, immunohistochemistry, and immunofluorescence.

Crafted with meticulous attention to detail, this antibody undergoes rigorous quality control measures to guarantee optimal performance and consistency. Its exceptional affinity for the PIRH2 protein ensures minimal background noise, allowing for precise and reliable data interpretation.

The PIRH2 Monoclonal Antibody is supplied in a convenient and user-friendly format, ensuring ease of use and compatibility with various experimental protocols. Its long shelf life and stability make it a cost-effective choice for laboratories and research institutions.

In summary, the PIRH2 Monoclonal Antibody is a state-of-the-art tool that empowers researchers to delve deeper into the intricate mechanisms of molecular biology. With its exceptional specificity, reliability, and ease of use, this antibody is an invaluable asset for any scientific investigation involving the PIRH2 protein.